ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 26 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $408,000 | -60.6% | 199,953 | -42.9% | 0.04% | -59.3% |
| Q2 2020 | $1,036,000 | -62.7% | 349,953 | -66.7% | 0.09% | -71.1% |
| Q1 2020 | $2,775,000 | -58.6% | 1,049,953 | -22.2% | 0.32% | -72.0% |
| Q4 2019 | $6,709,000 | -16.6% | 1,349,953 | 0.0% | 1.12% | -55.3% |
| Q3 2019 | $8,046,000 | -7.6% | 1,349,953 | 0.0% | 2.52% | +12.8% |
| Q2 2019 | $8,707,000 | -4.5% | 1,349,953 | 0.0% | 2.23% | +1.6% |
| Q1 2019 | $9,119,000 | +66.0% | 1,349,953 | 0.0% | 2.20% | +54.8% |
| Q4 2018 | $5,494,000 | -62.6% | 1,349,953 | 0.0% | 1.42% | -47.3% |
| Q3 2018 | $14,687,000 | – | 1,349,953 | – | 2.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|